Haddon Pantel, MD
Assistant Professor of Surgery (Colon and Rectal)Cards
About
Research
Publications
2024
Pelvic Floor Physical Therapy Prehabilitation (PrePFPT) for the prevention of low anterior resection syndrome
Coppersmith N, Schultz K, Esposito A, Reinhart K, Ray E, Leeds I, Pantel H, Reddy V, Longo W, Mongiu A. Pelvic Floor Physical Therapy Prehabilitation (PrePFPT) for the prevention of low anterior resection syndrome. Surgical Oncology Insight 2024, 1: 100097. DOI: 10.1016/j.soi.2024.100097.Peer-Reviewed Original ResearchLow anterior resection syndromeAnterior resection syndromePelvic floor physical therapyQuality of life outcomesSymptoms of low anterior resection syndromeImprove patient qualityPhysical therapyRectal cancerPrehabilitationDevelopment of low anterior resection syndromeStudy designTreatment of low anterior resection syndromeTreatment of rectal cancerIncidence of low anterior resection syndromeLife outcomesEvaluated pre-Patients' qualityRectal cancer patientsCancer patientsDevelopment of symptomsNeoadjuvant chemoradiotherapyDefecatory dysfunctionImproved recoveryInternational trialsSyndromeFive-year evaluation of Anal Cancer Screening Program in Men Who Have Sex With Men with HIV at Two Academic Center Clinics
Achhra A, Chan E, Applebaum S, Guerrero M, Hao R, Pantel H, Virata M, Fikrig M, Barakat L. Five-year evaluation of Anal Cancer Screening Program in Men Who Have Sex With Men with HIV at Two Academic Center Clinics. Clinical Infectious Diseases 2024, ciae541. PMID: 39492696, DOI: 10.1093/cid/ciae541.Peer-Reviewed Original ResearchHigh-resolution anoscopyAnal cytologyAnal cancer screening programAbnormal anal cytologyAcademic HIV clinicSquamous cell carcinomaRetrospective chart reviewHistory of smokingEligible populationCancer screening programDetecting HSILAbnormal cytologyTriage testCell carcinomaHIV clinicChart reviewOlder age groupsHSILFollow-upCytologyScreening programScreening testCenter clinicIncreasing ageEligible individualsAssociation Between Chemotherapy-Induced Peripheral Neuropathy and Low Anterior Resection Syndrome
Linhares S, Schultz K, Coppersmith N, Esposito A, Leeds I, Pantel H, Reddy V, Mongiu A. Association Between Chemotherapy-Induced Peripheral Neuropathy and Low Anterior Resection Syndrome. Cancers 2024, 16: 3578. PMCID: PMC11545659, DOI: 10.3390/cancers16213578.Peer-Reviewed Original ResearchLow anterior resection syndromeChemotherapy-induced peripheral neuropathyAnterior resection syndromeSystemic therapyRectal cancerPeripheral neuropathyAssociated with low anterior resection syndromeRetrospective review of patientsPlatinum-based chemotherapy agentsLow anterior resectionReview of patientsSphincter-preserving surgeryRectal cancer treatmentNeoadjuvant chemoradiationTumor distanceAnal vergeAnterior resectionRetrospective reviewChemotherapy-inducedChemotherapy agentsSide effectsCancer treatmentDebilitating conditionPatientsCIPNBy Any Other Name: Bowel Dysfunction After Proctectomy for Cancer and Its Predictive Factors in Administrative Databases
Leeds I, Coppersmith N, Moore M, Saleh A, Cruickshank K, Pantel H, Reddy V, Mongiu A. By Any Other Name: Bowel Dysfunction After Proctectomy for Cancer and Its Predictive Factors in Administrative Databases. Journal Of Surgical Research 2024, 303: 342-351. PMID: 39413695, DOI: 10.1016/j.jss.2024.09.027.Peer-Reviewed Original ResearchBowel dysfunctionRehabilitation proceduresPredictive factorsCosts of healthcare utilizationAssociated with bowel dysfunctionPopulation-based studyNeoadjuvant chemotherapy administrationLow anterior resection syndromeLow anterior resectionAdministrative claims dataRetrospective cohort studyAnterior resection syndromePostoperative bowel dysfunctionHealthcare utilizationPoisson regressionDiagnostic codesFollowed surgeryChemoradiation therapyFollow-up costsMultiagent chemotherapyStatistically significant covariatesAnterior resectionClaims dataCohort studyIndependent predictorsFor Whom the Bell Tolls: Assessing the Incremental Costs Associated With Failure-To-Rescue After Elective Colorectal SurgeryRunning Title: Cost of Failure-To-Rescue After Colorectal Surgery
Schultz K, Moore M, Pantel H, Mongiu A, Reddy V, Schneider E, Leeds I. For Whom the Bell Tolls: Assessing the Incremental Costs Associated With Failure-To-Rescue After Elective Colorectal SurgeryRunning Title: Cost of Failure-To-Rescue After Colorectal Surgery. Journal Of Gastrointestinal Surgery 2024, 28: 1812-1818. PMID: 39181234, DOI: 10.1016/j.gassur.2024.08.019.Peer-Reviewed Original ResearchFailure-to-rescueMedian total hospital costTotal hospital costsColorectal surgeryNational Inpatient SampleUneventful recoveryRetrospective study of adult patientsFailure-to-rescue patientsAssociated with increased healthcare costsStudy of adult patientsElective colorectal resectionHospital costsElective colorectal surgeryNationally representative cohortColorectal resectionElective colectomyPostoperative complicationsRetrospective studyAdult patientsRescue attemptsMedical futilityElective surgeryRepresentative cohortHealthcare costsPrimary outcome1224 PREOPERATIVE PSYCHOSOCIAL RISK BURDEN AMONG PATIENTS UNDEROING MAJOR THORACIC AND ABDOMINAL SURGERY
Park E, Schultz K, Pantel H, Mongiu A, Reddy V, Leeds I. 1224 PREOPERATIVE PSYCHOSOCIAL RISK BURDEN AMONG PATIENTS UNDEROING MAJOR THORACIC AND ABDOMINAL SURGERY. Gastroenterology 2024, 166: s-1850-s-1851. DOI: 10.1016/s0016-5085(24)04735-8.Peer-Reviewed Original Research
2023
The Predictors of Complete Pathologic Response in Rectal Cancer during the Total Neoadjuvant Therapy Era: A Systematic Review
Flom E, Schultz K, Pantel H, Leeds I. The Predictors of Complete Pathologic Response in Rectal Cancer during the Total Neoadjuvant Therapy Era: A Systematic Review. Cancers 2023, 15: 5853. PMID: 38136397, PMCID: PMC10742121, DOI: 10.3390/cancers15245853.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsTotal neoadjuvant therapyPathologic complete responseClinical complete responseNeoadjuvant therapyComplete responseSystematic reviewRectal cancerTumor responseClinical stage 2Complete pathologic responseRetrospective cohort studyRandomized clinical trialsHeterogeneity of studiesLevel of evidenceElectronic databases EmbaseIdentification of predictorsCancer treatment paradigmLong-term trialsNeoadjuvant chemotherapyTherapy eraPatient demographicsPreoperative predictorsClinical factorsClinicopathologic factorsCohort studyRare cases of colonic schwannomas
Gazivoda V, Wang D, Siddique M, Zeng J, Robert M, Pantel H, Mongiu A. Rare cases of colonic schwannomas. Journal Of Surgical Case Reports 2023, 2023: rjac438. PMID: 38163055, PMCID: PMC10757069, DOI: 10.1093/jscr/rjac438.Peer-Reviewed Original ResearchSpindle cell neoplasmTransverse colonMesenchymal tumorsCell neoplasmsProximal transverse colonSegmental transverse colectomyRare spindle cell tumorSpindle cell tumorsColonic schwannomaJumbo forcepsTransverse colectomyPrimary anastomosisSurveillance colonoscopyMucosal biopsiesSubmucosal lesionsColon massElderly malesSubmucosal resectionCell tumorsDeep biopsyElderly femalesSurgical decisionNinth caseRare caseCT scan1478. Evaluation Of Anal Cancer Screening Program in men who have sex with men (MSM) persons with HIV (PWH) At Two academic center HIV Clinics 2018-2022
Achhra A, Chan E, Applebaum S, Guerrero M, Hao R, Pantel H, Virata M, Barakat L. 1478. Evaluation Of Anal Cancer Screening Program in men who have sex with men (MSM) persons with HIV (PWH) At Two academic center HIV Clinics 2018-2022. Open Forum Infectious Diseases 2023, 10: ofad500.1314. PMCID: PMC10677807, DOI: 10.1093/ofid/ofad500.1314.Peer-Reviewed Original ResearchAnal dysplasiaAbnormal PapHIV clinicAnal cancer screening programsAmbulatory HIV clinicRetrospective chart reviewHistory of smokingCancer screening programsSquamous cell carcinomaAnal cytologyAntiretroviral therapyHIV careChart reviewClinic visitsMedian ageMultivariable analysisCell carcinomaScreening programPrior historyAge 35High riskType of insuranceBackground treatmentCharacteristics of peoplePWHTelehealth Availability for Cancer Care During the COVID-19 Pandemic: Cross-Sectional Study
Marks V, Hsiang W, Nie J, Umer W, Haleem A, Galal B, Pak I, Kim D, Salazar M, Pantel H, Berger E, Boffa D, Cavallo J, Leapman M. Telehealth Availability for Cancer Care During the COVID-19 Pandemic: Cross-Sectional Study. JMIR Cancer 2023, 9: e45518. PMID: 37917149, PMCID: PMC10654905, DOI: 10.2196/45518.Peer-Reviewed Original ResearchCancer HospitalCancer careTelehealth availabilityTotal admissionsTelehealth servicesCancer typesBreast cancer careComprehensive cancer programsCross-sectional studySkin cancer careFacility-level factorsNational Cancer InstituteCOVID-19 pandemicTelehealth visitsAccountable care organizationsCommon cancerCancer programsOutpatient careCancer sitesNew patientsCancer InstitutePatientsSkin cancerHospitalMost hospitals
Clinical Care
Overview
Haddon Pantel, MD, is a fellowship trained colorectal surgeon who treats benign, inflammatory, and cancerous diseases of the colon, rectum, and anus, including such problems as diverticulitis and inflammatory bowel disease. He earned his medical degree from the University of Vermont followed by a General Surgery Residency at Lahey Clinic, and he subsequently completed fellowship training in Colon and Rectal Surgery at the Lahey Clinic as well.
Many of his patients have symptoms and problems that they are uncomfortable talking about. “We try to give all this a sense of normalcy,” he says. “It is normal for us, because it's all we see.” Dr. Pantel is passionate about colorectal surgery because it is an area of medicine where he is able to help a lot of people. The diseases are common and usually treatable when they are diagnosed early, Dr. Pantel says. “We know the patient’s history, and we can provide a lifetime of care.”
He recommends people talk to their doctor right away if they notice symptoms such as blood in the stool—whether it is bright red blood or dark blood and tarry stools—as it could be a sign of colorectal cancer. It’s also important to follow screening recommendations, Dr. Pantel says. The American Society of Colon & Rectal Surgeons now recommends that people at average risk of colorectal cancer start screening at age 45. This can be done with an at-home test that looks for signs of cancer in a person’s stool or a visual exam such as a colonoscopy. Dr. Pantel points out that a colonoscopy is not only a screening tool, but also a way for doctors to remove any polyps that could become invasive cancers. “Colonoscopies are akin to wearing your seatbelt. Granted, it's a little bit more involved than just reaching over and buckling it every time you get in the car. But, it’s a preventive measure and an effective one,” he says.
Clinical Specialties
Fact Sheets
Colonoscopy
Learn More on Yale MedicineRectal Bleeding
Learn More on Yale MedicineColorectal Polyps
Learn More on Yale MedicineHyperthermic Intraperitoneal Chemotherapy (HIPEC)
Learn More on Yale Medicine
Board Certifications
Colon and Rectal Surgery
- Certification Organization
- AB of Colon and Rectal Surgery
- Original Certification Date
- 2021
Surgery General
- Certification Organization
- AB of Surgery
- Original Certification Date
- 2019
Yale Medicine News
News
News
- March 28, 2024
Smilow Shares: Updates in Colorectal Cancer Screening, Diagnosis, Prevention, and Treatment
- February 20, 2024
Dr. Haddon Pantel on Yale Cancer Answers
- January 08, 2023
Digestive Health Learning Series Back for 2023!
- February 24, 2022Source: Eat This, Not That
Warning Signs You Have Colon Cancer Now